← All indications
Arthritis
Acute or chronic inflammation of JOINTS.
Subtype terms (12)
More specific conditions that are subtypes of Arthritis in the MeSH hierarchy.
- Arthritis, Experimental
3 drugs approved
- Arthritis, Infectious
18 drugs (14 approved, 4 experimental)
- Arthritis, Juvenile
95 drugs (71 approved, 24 experimental)
- Arthritis, Psoriatic
93 drugs (59 approved, 34 experimental)
- Arthritis, Rheumatoid
638 drugs (246 approved, 392 experimental)
- Chondrocalcinosis
10 drugs (9 approved, 1 experimental)
- Gout
114 drugs (68 approved, 46 experimental)
- Osteoarthritis
351 drugs (156 approved, 195 experimental)
- Periarthritis
4 drugs (3 approved, 1 experimental)
- Rheumatic Fever
16 drugs (8 approved, 8 experimental)
- Sacroiliitis
5 drugs (4 approved, 1 experimental)
- Spondylarthritis
12 drugs (8 approved, 4 experimental)
Drugs by status
Approved for this indication (19)
Phase 4 trials (29)
- propofol
- urea
- oxycodone
- tofacitinib
- etanercept
- gabapentin
- sevoflurane
- ketorolac
- platelet-rich plasma
- lumiracoxib
- rimabotulinumtoxinB
- ropivacaine
- epinephrine
- remimazolam
- rocuronium
- levobupivacaine
- celecoxib
- desflurane
- bupivacaine
- vancomycin
- vecuronium
- fentanyl
- triamcinolone
- tranexamic acid
- naloxone
- prednisolone
- sodium chloride
- tenofovir alafenamide
- varicella zoster virus glycoprotein e antigen
Phase 3 trials (22)
Phase 2 trials (35)
- metformin
- allopurinol
- denosumab
- bfh772
- 99mtc
- betamethasone
- fab-fragment of anti-human cd4
- folic acid
- hydroxychloroquine
- olokizumab
- colchicine
- valsartan
- rhubarb
- tramadol
- ulodesine
- human fecal microbiota
- autologous adipose tissue
- live attenuated varicella vaccine
- angelica
- rhizoma atractylodis
- cortex phellodendrine
- radix cyathula
- coix seed
- cotton bi xie
- rhizoma smilacis glabrae
- rhizoma arisaema
- pseudobulbus cremastrae seu pleiones
- anakinra
- turmeric
- calcipotriene
- +5 more
Phase 1 trials (13)
Other trials (38)
- sumatriptan
- ethyl-alpha-guanido-methyl ethanoate
- asimadoline
- autologous plasma
- ketamine
- cocoa bean
- cyclobenzaprine
- topiramate
- meloxicam
- tizanidine
- mycophenolate
- tenoxicam
- anastrozole
- tocilizumab
- allogeneic adipose derived mesenchymal stem cell
- bifidobacterium bifidum
- coffee
- seal oil
- spinach
- upadacitinib
- morphine
- letrozole
- flurbiprofen
- broccoli
- baclofen
- prilocaine
- aminophenazone cyclamate
- omega-3 fatty acids
- monomethyl fumarate
- etoricoxib
- +8 more
Organizations
Organization Involved with Phase 4 Indications (262)
- Rheumatism Hospital Graasten
- University of Paris
- Janssen Pharmaceutica NV
- Lille Catholic University
- Sun Yat-Sen University
- University of Caen-Normandie
- Norwegian University of Science and Technology
- University of Cincinnati
- François Rabelais University
- OrthoCarolina Research Institute
- Depolabo
- University of Turku
- University of Pavia
- King Edward Medical University
- Parexel
- Spanish Foundation of Rheumatology
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- University of Lille
- Gyeongsang University
- Wenzhou Medical University
- Keimyung University
- First People's Hospital of Foshan
- University of L'Aquila
- University of Franche-Comté
- Government of Norway
- Vita-Salute University of Milano. Italy
- Amgen
- State of New York
- Harvard University
- Cancer Research Network
- +232 more
Organization Involved with Phase 3 Indications (158)
- Cinnagen
- Chang Gung University
- University of Haifa
- Han Wha Pharma Co., Ltd.
- Hengrui Therapeutics, Inc.
- Assiut University
- Aix-University of Marseille
- Celltrion
- National Center for Complementary and Integrative Health (NCCIH)
- Bausch Health Companies
- Emek Medical Center
- Centro Reumatologico Strusberg
- Farmak
- SinoMab Pty Ltd
- R-Biopharm
- Ewha Womans University
- Catalysis SL
- Merck KGaA
- Humanis Klinikum Niederosterreich
- EMS S/A
- Illinois Bone & Joint Institute
- Fresenius
- Nichi-Iko Pharmaceutical Co., Ltd.
- Atención Integral en Reumatología
- QUID Quality in Drugs and Devices Latin American Consulting SRL
- Vertex
- Momenta Pharmaceuticals
- Arthritis and Rheumatic Disease Specialties
- Tzu Chi University
- Dong-A University
- +128 more
Organization Involved with Phase 2 Indications (158)
- NovImmune SA
- University of Leipzig
- Zhongyuan Union Stem Cell Bio-engineering Corporation
- Maidstone & Tunbridge Wells NHS Trust
- Indiana University
- Celltex Therapeutics Corporation
- University of Heidelberg
- BioStrategics Consulting Ltd
- Friedrich Alexander University
- Scios
- University of Colorado
- BioCryst
- Aclaris Therapeutics, Inc.
- Chelsea Therapeutics
- Virginia Mason Medical Center
- Maoxiang Group Jilin Pharmaceutical Co., Ltd.
- Navidea Biopharmaceuticals
- Hanlim Pharm. Co., Ltd.
- TRB Chemedica
- Aix Scientifics
- Hope Biosciences
- Immune Tolerance Network
- Icahn School of Medicine at Mount Sinai
- The EMMES Corporation
- Novo Nordisk
- Root Causes Medicine
- Universidad Austral de Chile
- Advanced Accelerator Applications
- Xoma
- Rebecca MacDonald Centre for Arthritis
- +128 more
Organization Involved with Phase 1 Indications (64)
- Jilin University
- Hanmi Pharmaceutical
- PMG Pharm Co., Ltd
- Five Prime Therapeutics
- Orlando Clinical Research Center
- Thermo Fisher Scientific
- Gedeon Richter Ltd.
- Biointegrator LLC
- University of Southern California
- ZetrOZ, Inc.
- Medical Pain Consultants
- Sadat City University
- Comac Medical
- Archigen Biotech Limited
- ICON
- Biotie Therapies
- Shanghai Zhangjiang Biotechnology Limited Company
- Seaview Jacksonville, LLC
- Russian Academy of Medical Sciences
- Altasciences Company Inc.
- Northwestern University
- Shenzhen Hornetcorn Bio-technology Company, LTD
- Futian People's Hospital
- Hutchison MediPharma
- ARENSIA, Moldova
- Shahid Beheshti University of Medical Sciences
- Nucleus Network Ltd
- Covance
- Morphotek
- Eden Biologics
- +34 more
Organization Involved with Other Experimental Indications (45)
- University of Exeter
- McMaster University
- University of Bath
- Anhui Medical University
- Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc.
- Cornell University
- Aestique Medical Center
- Artesis University College
- Shanxi Medical University
- Rheumatoid Arthritis Investigational Network
- University of Manitoba
- Tufts University
- Alexandria University
- University of Wisconsin
- J.A.R. Laboratories
- University of Indonesia
- University of British Columbia
- Physicians Committee for Responsible Medicine
- Swedish Foundation for Strategic Research
- Government of Quebec
- ImmunoPharma AS
- Dalhousie University
- Ronald J. Rapoport, MD
- University of Minnesota
- Wellcome Trust
- Free University of Brussels
- Anhui College of Traditional Chinese Medicine
- University of Antwerp
- Tianjin Medical University
- Changhai Hospital
- +15 more